Identification and preclinical characterization of a novel and potent poly (ADP-ribose) polymerase (PARP) inhibitor ZYTP1.
Jain, Mukul R
Identification and preclinical characterization of a novel and potent poly (ADP-ribose) polymerase (PARP) inhibitor ZYTP1. [electronic resource] - Cancer chemotherapy and pharmacology 10 2018 - 635-647 p. digital
Publication Type: Journal Article
1432-0843
10.1007/s00280-018-3653-1 doi
Animals
Apoptosis--drug effects
Biological Availability
Breast Neoplasms--drug therapy
Cell Line, Tumor
Cell Proliferation--drug effects
Colonic Neoplasms--drug therapy
DNA Damage--drug effects
Dogs
Drug Monitoring--methods
Humans
Mice
Poly(ADP-ribose) Polymerase Inhibitors--pharmacology
Poly(ADP-ribose) Polymerases--metabolism
Rats
Rats, Wistar
Tankyrases--antagonists & inhibitors
Treatment Outcome
Xenograft Model Antitumor Assays
Identification and preclinical characterization of a novel and potent poly (ADP-ribose) polymerase (PARP) inhibitor ZYTP1. [electronic resource] - Cancer chemotherapy and pharmacology 10 2018 - 635-647 p. digital
Publication Type: Journal Article
1432-0843
10.1007/s00280-018-3653-1 doi
Animals
Apoptosis--drug effects
Biological Availability
Breast Neoplasms--drug therapy
Cell Line, Tumor
Cell Proliferation--drug effects
Colonic Neoplasms--drug therapy
DNA Damage--drug effects
Dogs
Drug Monitoring--methods
Humans
Mice
Poly(ADP-ribose) Polymerase Inhibitors--pharmacology
Poly(ADP-ribose) Polymerases--metabolism
Rats
Rats, Wistar
Tankyrases--antagonists & inhibitors
Treatment Outcome
Xenograft Model Antitumor Assays